Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
eXludus Technologies was a software company specializing in high-performance computing (HPC) and grid management solutions designed to optimize multi-core processor efficiency. The company's technology was particularly critical for the life sciences sector, where it provided the infrastructure necessary to accelerate bioinformatics tasks such as genomic sequencing and molecular modeling. Their flagship product, the eXludus Job Management System (JMS), utilized a unique "grid-on-a-chip" approach to maximize computational throughput and resource utilization. By streamlining data-intensive research workflows, eXludus helped biotechnology firms and academic institutions handle the massive datasets generated by modern laboratory equipment. The company was acquired by Terascala in 2008 to integrate its advanced scheduling and management capabilities into high-throughput storage solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on eXludus.